Atrial Flutter Market Outlook 2025-2035: The atrial flutter market is expected to exhibit a CAGR of 4.56% during 2025-2035. The atrial flutter market is growing as cardiovascular diseases become more ...

The safety of abelacimab as compared with a direct oral anticoagulant in patients with atrial fibrillation is ... adjustment for multiple testing. No imputation was performed for missing data ...

A 2024 study followed the outcomes of 260,492 adults hospitalized for AFib or atrial flutter, a closely related cardiac rhythm change. The authors reported 45% of the people had died within 10 years, ...

But when individuals learn to say no more often, it can have huge benefits for their careers and organizations, says Dr. Sunita Sah. A psychologist and professor at Cornell’s SC Johnson College ...

This no-implant atrial shunt could offer an effective treatment for heart failure. [Image courtesy of Alleviant Medical] Alleviant Medical announced today that it raised $90 million to fund the ...

In the COMPANION trial, 1520 patients with heart failure in functional status/NYHA class III/IV, QRS width greater than ... in the German guideline IIb C; Atrial fibrillation, EF less than or ...

Main outcome measures Primary outcome measures were quality of shared decision making measured by OPTION12, knowledge of atrial fibrillation and its management ... of shared decision making and ...

“These findings informed the design of the ALLAY-HFrEF trial, which is testing a novel device that creates an atrial shunt and leaves no permanent implant behind.” The cardiovascular device ...

Jiangsu Provincial Key Laboratory of Advanced Robotics, School of Mechanical and Electric Engineering, Soochow University, Suzhou 215137, China ...

This project is for Electrocardiogram(ECG) signal algorithms design and validation, include preprocessing, QRS-Complex detection, embedded system validation, ECG ...